2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
作者信息
Heidenreich Paul A, Fonarow Gregg C, Breathett Khadijah, Jurgens Corrine Y, Pisani Barbara A, Pozehl Bunny J, Spertus John A, Taylor Kenneth G, Thibodeau Jennifer T, Yancy Clyde W, Ziaeian Boback
出版信息
Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e000099. doi: 10.1161/HCQ.0000000000000099. Epub 2020 Nov 2.
Abstract
摘要
相似文献
1
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2020年美国心脏病学会/美国心脏协会心力衰竭成人患者临床性能和质量指标：美国心脏病学会/美国心脏协会性能指标特别工作组报告
Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e000099. doi: 10.1161/HCQ.0000000000000099. Epub 2020 Nov 2.
2
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures.2024 年更新版 2020 ACC/AHA 心力衰竭成人临床性能和质量指标：美国心脏协会/美国心脏病学会联合绩效测量委员会的报告。
Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e000132. doi: 10.1161/HCQ.0000000000000132. Epub 2024 Aug 8.
3
2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2018年美国心脏病学会/美国心脏协会心脏康复临床绩效与质量指标：美国心脏病学会/美国心脏协会绩效指标工作组报告
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e000037. doi: 10.1161/HCQ.0000000000000037.
4
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.美国心脏病学会基金会/美国心脏协会绩效评估特别工作组及美国医学协会-医师绩效改进联盟发布的《2011年成人心力衰竭患者ACCF/AHA/AMA-PCPI绩效评估报告》
Circulation. 2012 May 15;125(19):2382-401. doi: 10.1161/CIR.0b013e3182507bec. Epub 2012 Apr 23.
5
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.美国心脏病学会基金会/美国心脏协会绩效指标特别工作组及美国医学协会-医师绩效改进联合会发布的《2011年成人心力衰竭患者ACCF/AHA/AMA-PCPI绩效指标报告》
J Am Coll Cardiol. 2012 May 15;59(20):1812-32. doi: 10.1016/j.jacc.2012.03.013. Epub 2012 Apr 23.
6
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2017年美国心脏协会/美国心脏病学会关于ST段抬高型和非ST段抬高型心肌梗死成人患者的临床性能和质量指标：美国心脏病学会/美国心脏协会性能指标特别工作组报告
Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10). doi: 10.1161/HCQ.0000000000000032.
7
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2019年美国心脏协会/美国心脏病学会成人高血压临床绩效与质量指标：美国心脏病学会/美国心脏协会绩效指标特别工作组报告
Circ Cardiovasc Qual Outcomes. 2019 Nov;12(11):e000057. doi: 10.1161/HCQ.0000000000000057. Epub 2019 Nov 12.
8
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2020年美国心脏病学会/美国心脏协会心力衰竭成人患者临床绩效与质量指标：美国心脏病学会/美国心脏协会绩效指标特别工作组报告
J Am Coll Cardiol. 2020 Nov 24;76(21):2527-2564. doi: 10.1016/j.jacc.2020.07.023. Epub 2020 Nov 2.
9
2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures.《2020年美国心脏病学会/美国心脏协会成人心力衰竭临床绩效与质量指标2024年更新：美国心脏协会/美国心脏病学会绩效指标联合委员会报告》
J Am Coll Cardiol. 2024 Sep 17;84(12):1123-1143. doi: 10.1016/j.jacc.2024.05.014. Epub 2024 Aug 8.
10
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新：美国心脏病学会/美国心脏协会临床实践指南特别工作组及美国心力衰竭学会的报告
Circulation. 2017 Aug 8;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Epub 2017 Apr 28.
引用本文的文献
1
Feasibility and Safety of Early Cardiac Rehabilitation Using Remote Electrocardiogram Monitoring in Patients with Cardiac Surgery: A Pilot Study.心脏手术后患者使用远程心电图监测进行早期心脏康复的可行性和安全性：一项初步研究。
J Clin Med. 2025 Jul 10;14(14):4887. doi: 10.3390/jcm14144887.
2
Optimal Initial Intravenous Loop Diuretic Dosing in Acute Decompensated Heart Failure.急性失代偿性心力衰竭的最佳初始静脉用袢利尿剂剂量
JACC Adv. 2024 Sep 7;3(10):101250. doi: 10.1016/j.jacadv.2024.101250. eCollection 2024 Oct.
3
Future of Patient-Reported Outcomes: Bringing Patients' Voices Into Health Care.患者报告结局的未来：让患者的声音融入医疗保健
Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e010008. doi: 10.1161/CIRCOUTCOMES.124.010008. Epub 2024 Sep 17.
4
Optimization of Guideline-Directed Medical Therapy During Hospitalization for Heart Failure: Mind the Gap!心力衰竭住院期间指南导向药物治疗的优化：注意差距！
JACC Adv. 2024 Feb 14;3(7):100819. doi: 10.1016/j.jacadv.2023.100819. eCollection 2024 Jul.
5
Burden from Study Questionnaire on Patient Fatigue in Qualitative Congestive Heart Failure Research.定性充血性心力衰竭研究中患者疲劳情况研究问卷的负担
J Cardiovasc Dev Dis. 2024 Mar 24;11(4):96. doi: 10.3390/jcdd11040096.
6
Development of delivery indicators and delivery enablers for cardiovascular disease in the UK: a modified Delphi study.英国心血管疾病分娩指标和促进因素的制定：一项改良 Delphi 研究。
BMJ Open Qual. 2024 Feb 26;13(1):e002634. doi: 10.1136/bmjoq-2023-002634.
7
Association between performance measures and clinical outcomes in patients with heart failure in China: Results from the HERO study.中国心力衰竭患者的性能指标与临床结局之间的关联：HERO研究结果
Clin Cardiol. 2024 Feb;47(2):e24233. doi: 10.1002/clc.24233.
8
Acceptability of a Text Message-Based Mobile Health Intervention to Promote Physical Activity in Cardiac Rehabilitation Enrollees: A Qualitative Substudy of Participant Perspectives.基于短信的移动健康干预措施在促进心脏康复患者身体活动中的可接受性：参与者观点的定性子研究。
J Am Heart Assoc. 2024 Jan 16;13(2):e030807. doi: 10.1161/JAHA.123.030807.
9
Challenges of Health Data Use in Multidisciplinary Chronic Disease Care: Perspective from Heart Failure Care.多学科慢性病护理中健康数据使用的挑战：来自心力衰竭护理的视角
J Cardiovasc Dev Dis. 2023 Dec 5;10(12):486. doi: 10.3390/jcdd10120486.
10
Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction.急性心肌梗死后至少40天，左心室射血分数≤35%的患者植入心脏复律除颤器。
Am Heart J Plus. 2022 Jul;19. doi: 10.1016/j.ahjo.2022.100186.
本文引用的文献
1
Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction.沙库巴曲缬沙坦与 ACE/ARB 治疗射血分数降低的心力衰竭的疗效比较。
JACC Heart Fail. 2020 Jan;8(1):43-54. doi: 10.1016/j.jchf.2019.08.003. Epub 2019 Dec 11.
2
Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis.基于运动的心力衰竭康复治疗：Cochrane 系统评价、荟萃分析和试验序贯分析。
JACC Heart Fail. 2019 Aug;7(8):691-705. doi: 10.1016/j.jchf.2019.04.023. Epub 2019 Jul 10.
3
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.心力衰竭治疗变化与患者健康状况的关联：来自 CHAMP-HF 的真实世界证据。
JACC Heart Fail. 2019 Jul;7(7):615-625. doi: 10.1016/j.jchf.2019.03.020. Epub 2019 Jun 5.
4
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.在PIONEER-HF试验中随机分配接受沙库巴曲缬沙坦或依那普利治疗的急性失代偿性心力衰竭患者的临床结局
Circulation. 2019 May 7;139(19):2285-2288. doi: 10.1161/CIRCULATIONAHA.118.039331.
5
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭的药物治疗滴定。
J Am Coll Cardiol. 2019 May 21;73(19):2365-2383. doi: 10.1016/j.jacc.2019.02.015. Epub 2019 Mar 4.
6
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.血管紧张素-脑啡肽酶抑制剂在急性失代偿性心力衰竭中的应用。
N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11.
7
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation.β受体阻滞剂在慢性心力衰竭合并心房颤动患者中的疗效与剂量相关。
Int J Cardiol. 2018 Dec 15;273:141-146. doi: 10.1016/j.ijcard.2018.08.012. Epub 2018 Aug 6.
8
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.射血分数降低的心力衰竭的药物治疗：CHAMP-HF 注册研究。
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070.
9
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure.心力衰竭门诊患者的性别、种族/民族和社会经济地位的健康状况差异。
JACC Heart Fail. 2018 Jun;6(6):465-473. doi: 10.1016/j.jchf.2018.02.002.
10
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.心力衰竭门诊患者不同医疗实践中的健康状况差异：来自CHAMP-HF（改变心力衰竭患者管理）注册研究的见解
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004668. doi: 10.1161/CIRCOUTCOMES.118.004668.
Zotero 插件